home All News open_in_new Full Article

Biontech und Bristol Myers Squibb kooperieren bei Krebsmedikamenten

Es geht um den Wirkstoff, in den die Mainzer große Hoffnungen stecken bei der Behandlung von Tumoren. Dessen Entwicklung soll nun gemeinsam vorangetrieben werden.


today 5 d. ago attach_file Society

attach_file Society
attach_file Society
attach_file Politics
attach_file Society
attach_file Society
attach_file Politics
attach_file Society
attach_file Sport
attach_file Society
attach_file Society
attach_file Society
attach_file Culture
attach_file Society
attach_file Society
attach_file Society
attach_file Society
attach_file Society
attach_file Society
attach_file Society
attach_file Society


ID: 2288660185
Add Watch Country

arrow_drop_down